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 Renal fi brosis is the fi nal common path-
way for all kidney diseases that lead to 
nephron destruction and terminal renal 
failure, regardless of the initial cause. Th e 
histopathology of renal fi brosis features 
infi ltration of infl ammatory cells, tubular-
cell loss, fibroblast accumulation, and 
rarefaction of the peritubular microvas-
culature accompanied by the deposition 
of interstitial matrix and glomerulo-
sclerosis. Two hypotheses have been 
put forward to account for this disease 
progression. First and traditionally, it is 
proposed that the primary event is 
glomerular. Following the glomerular 
injury, direct toxicity of glomerular pro-
teinuria to the tubules, protein-bound 
cytokines from the plasma infi ltrate the 
tubular microenvironment, and possible 
cytokine leakage through bulk fl uid fl ow 
from the aff erent arteriole directly into 
the interstitial spaces leads to secondary 
tubulointerstitial damage. The second 
hypothesis is that the primary event is 
tubular. Th e tubular hypothesis can be 
traced to a paper by Risdon  et al. , 1 who 
first showed in human renal biopsies 
40 years ago that progression to renal fail-
ure correlated more closely with tubular 
than with glomerular damage. Th e bulk of 
evidence in favor of renal fi brosis aft er 
tubular injury was obtained  in vitro with 
the use of proximal tubular cells in cul-
ture. To address tubular injury as the ini-
tiating factor  in vivo is diffi  cult because of 
the complexity of the kidney. Animal 
models of acute kidney injury induced by 
toxic chemicals or ischemic reperfusion 
simultaneously involve several diff erent 
kinds of cells, including tubular epithelial 
cells, endothelial cells, and podocytes. 
Although the two hypotheses are not 
mutually exclusive and are always mixed 
together, a new study by Grgic  et al. 2 (this 
issue) provides fascinating data in this 
context. 
 Grgic  et al. 2 developed a unique model 
of kidney injury in the mouse using Cre-
LoxP technology to selectively activate 
expression of the simian diphtheria toxin 
receptor (DTR) in renal epithelia that 
derived from the metanephric mesen-
chyme. Th ey used this model to evaluate 
the acute and chronic consequences of 
epithelial injury. Th ree days aft er the injec-
tion of a sublethal dosage of diphtheria 
toxin (0.15   g / kg), the most prominent 
change of acute tubular injury was con-
fi ned to the S1 and S2 segments of the 
proximal tubule. Th ere were no morpho-
logical changes in glomeruli, endothelial 
cells, and collecting ducts. Acute epithelial 
injury was promptly followed by infi ltra-
tion of CD3-positive T lymphocytes and 
macrophages, and robust tubular-cell pro-
liferation led to complete recovery aft er a 
single event. In contrast, repeated injury 
to renal epithelial cells resulted in mala-
daptive repair with rarefaction of intersti-
tial capillaries, interstitial fi brosis, and 
glomerulosclerosis that was highly cor-
related with the degree of interstitial fi bro-
sis. The authors conclude that injury 
restricted to the proximal tubules can 
drive the formation of interstitial fi brosis, 
capillary loss, and potentially glomerulo-
sclerosis, expanding a direct role for 
damaged tubule epithelium in the patho-
genesis of chronic kidney disease. Grgic 
 et al. 2 are the first to provide evidence 
 in vivo to show that selective damage to 
the renal tubules can initiate the vicious 
circle of renal fi brosis and lead to chronic 
renal failure. 
 During the process of repeated injury 
( Figure 1 ), the regenerating renal tubular 
cells remain dediff erentiated and secrete 
cytokines for repair. Some of the cytokines 
are detrimental to renal repair. Among 
these, the epicenter for early molecular 
action of renal fi brosis by tubular cells is 
through nuclear factor   light chain 
enhancer of activated B cells (NF-  B). 3 
Th e activation of NF-  B will initiate the 
downstream release of plasminogen acti-
vator inhibitor-1 or chemokines and 
growth factors such as interleukin-1, 
interleukin-6, transforming growth fac-
tor-  , monocyte chemotactic protein-1, 
chemokine ligand 5 (CCL5), or tumor 
necrosis factor-  . 4 Th ese cytokines will 
induce a process leading to renal fi brosis 
with recruitment of infl ammatory cells, 5 
and cell-cycle arrest in G2 / M activated c-
Jun N-terminal kinase (JNK) in the 
injured tubular cells. 6 Th e activation and 
migration of pericytes 7 and fi broblasts in 
the interstitial area of injured kidney may 
contribute to capillary rarefaction, pro-
gressive ischemia, and aggravation of 
renal fi brosis. Although the mechanism 
underlying the process of renal fi brosis 
aft er repeated tubular injury is not fully 
understood at present, the work of Grgic 
 et al. 2 opens a new window for studying 
the detailed mechanism. It is possible that 
in the near future, intervention targeting 
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the signaling pathway in the injured tubu-
lar cells might prevent end-stage renal 
disease. 
 One critical point in the study by 
Grgic  et al. 2 is the use of bigenic Six2-
GFPCre   +   ;iDTR   +   mice (DTR rec mice) to 
explore the tubular hypothesis. To obtain 
the model system of epithelial cell-specifi c 
injury in the kidney, they crossed the Six2-
GFPCre mouse with a Cre-inducible 
diphtheria toxin receptor (iDTR) trans-
genic mouse, generating bigenic DTR rec 
mice. Mice homozygous for the iDTR 
mutation have the simian DTR inserted 
into the Gt(ROSA)26Sor (ROSA26) locus. 
Widespread expression of DTR is blocked 
by an upstream LoxP-flanked stop 
sequence. When bred to Six2-GFPCre 
recombinase-expressing mice, the stop 
sequence is deleted in tissues where Cre is 
present, permitting DTR expression. Th e 
transcription factor Six2 is transiently 
expressed during the developmental 
period of active nephrogenesis in the cap 
mesenchyme, which gives rise to all neph-
ron cell types derived from the metane-
phric mesenchyme, including podocytes, 
proximal tubules, loop of Henle, and distal 
tubules. 8,9 Th eoretically, DTR rec mice are 
supposed to have activated DTR even in 
podocytes, since when the Six2-GFPCre 
mouse was crossed with a reporter mouse, 
podocytes were also labeled. 10 In the study 
by Grgic  et al. 2 the podocyte damage is 
excluded by negative TUNEL assay in 
glomeruli and normal morphological 
changes of podocytes 3 days aft er injury. 
Th e lack of glomerular damage found by 
Grgic  et al. 2 could be due to poor expres-
sion of the Cre in glomerular epithelia 
(that is, a happy accident). However, 
because few glomeruli could be thor-
oughly analyzed for damage, the possibil-
ity that the sampled glomeruli are not 
representative cannot be excluded — that 
is, that subtly damaged glomeruli were 
missed and they generated glomerular 
sclerosis. Finally, one should also consider 
the possibility that current methods to 
detect cellular damage might not be suf-
fi ciently sensitive. With these caveats, the 
findings of Grgic  et al. 2 suggest that 
restricted tubular damage might cause 
renal fi brosis and glomerular sclerosis. 
 In summary, this study provides new 
evidence, using bigenic DTR rec mice, that 
repeated acute kidney injury induced by 
tubular damage results in chronic kidney 
disease. Many questions remain regarding 
the potential mechanisms involved in this 
process. It is hoped that these intriguing 
fi ndings will stimulate further research 
into the direct actions of injured tubular 
cells in renal fi brosis, a pathological proc-
ess that is in desperate need of innovative 
therapies. 
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 Figure 1  |  A simplified scheme of the proposed mechanisms that lead to progressive renal fibrosis. After repeated acute kidney injury (AKI), 
the dedifferentiated tubular cells secrete cytokines for repair. Some cytokines could recruit inflammatory cells, activate c-Jun N-terminal kinase (JNK) 
in G2 / M arrested tubule cells, and activate pericytes. These will lead to tubular atrophy, interstitial fibrosis, capillary rarefaction, glomerulosclerosis, 
and chronic kidney disease. CTGF, connective tissue growth factor; PDGF, platelet-derived growth factor; TGF-  , transforming growth factor-  . 
(Adapted from refs. 6,7.) 
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 More than 100 years ago, we started to 
realize that there are correlations between 
dietary sodium consumption and high 
blood pressure. When people left  tribal 
communities and became part of indus-
trial society, increased dietary sodium was 
accompanied by high blood pressure in 
one-third of them. 1 Th e concept of sodium 
sensitivity was born aft er this observation, 
and today we believe that the majority of 
essential hypertension fi ts into this cate-
gory. Furthermore, another series of 
experiments confirmed that a high-
sodium diet causes vascular damage even 
without changes in blood pressure. 2 
In addition to a signifi cant decrease in 
blood pressure by the Dietary Approaches 
to Stop Hypertension (DASH) diet, 
Bibbins-Domingo  et al. also projected sig-
nifi cant improvement in cardiovascular 
morbidity and mortality with dietary salt 
reduction. 3 
 Although compelling evidence has 
shown that high sodium intake is associated 
with high blood pressure, vascular damage, 
and higher mortality in the general popula-
tion, the evidence is still weak in patients on 
chronic hemodialysis. Mc Causland  et al. 4 
(this issue) have taken an important step by 
exploring the potential role of dietary 
sodium intake in mortality of patients on 
chronic hemodialysis. In this study, the 
authors undertook a  post hoc analysis of 
1770 subjects from the Hemodialysis 
(HEMO) Study on whom complete data 
were available. Th e dietary sodium intake, 
estimated on the basis of 2-day dietary 
assisted recalls, correlated with ultrafi ltra-
tion requirements, serum sodium, systolic 
blood pressure, and all-cause mortality. 
After case-mix adjustment, they found 
that higher dietary sodium intake was 
marginally associated with higher ultrafi l-
tration requirement and all-cause mortality. 
Interestingly, reported dietary sodium, 
sodium / calorie ratio, and sodium / 
potassium ratio were not associated with 
systolic blood pressure. Finally, there was 
no association between restrictive (    2  g / d) 
versus liberal (>2  g / d) sodium consumption 
and all-cause mortality. 4 
 Although this study uses data from a 
landmark experiment on hemodialysis 
patients (the HEMO Study), and the 
authors performed an excellent analysis to 
examine their hypothesis, there are some 
issues that are worth careful attention. 
Th e fi rst is the method of estimating die-
tary sodium. The HEMO Study used 
dietary recall to estimate sodium con-
sumption. Several studies have reported a 
weak correlation between 24-h dietary 
recall and 24-h urinary measurement of 
sodium. 5 In general, dietary recalls tend 
to underestimate total dietary sodium 
intake. 6 Furthermore, some people, espe-
cially on hemodialysis, may tend to under-
report their daily nutrient consumption 
and total calorie intake. Mc Causland 
 et al. 4 report that the mean caloric intake 
in the total cohort was 1523 ± 547  kcal / d. 
Given that malnourished patients (serum 
albumin   <  2.6  g / dl) had been excluded 
from the HEMO Study, this low caloric 
intake among the study population might 
be at least in part due to underreporting 
and / or underestimation of the total caloric 
intake. In this study, daily calorie intake 
was strongly associated with reported 
dietary sodium intake even aft er adjust-
ment for case mix and other confounders. 
Th ese fi ndings are mostly suggestive of 
underestimation of total dietary sodium 
by the participants in the HEMO Study. 
 Th e second concern is the magnitude of 
higher mortality risk seen with high 
sodium consumption compared with that 
of  ‘ recommended ’ dietary sodium of 
about 2  g / d. Only the fourth quartile of 
dietary sodium consumption was slightly 
associated with increased all-cause mor-
tality, when compared with the fi rst quar-
tile (and not with the  ‘ recommended ’ 
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